What is the onset of action for lignocaine (lidocaine) when used as a local anesthetic?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Onset of Action for Lignocaine (Lidocaine)

Lignocaine has an almost immediate onset of action when administered intrapleurally, and should therefore be given just before the sclerosant during pleurodesis procedures 1. However, the onset time varies significantly depending on the route and method of administration.

Route-Specific Onset Times

Topical/Mucosal Application

  • 3-5 minutes for topical anesthesia on mucous membranes 2
  • 2-5 minutes when used with epinephrine for topical anesthesia 3
  • Ineffective when applied to intact skin 2

Infiltrative/Injection Anesthesia

  • Approximately 1 minute for standard infiltrative anesthesia 3
  • 1.3 minutes (range 1-2.7 minutes) for digital nerve blocks 4
  • 11.2 ± 5.1 minutes for intravenous regional anesthesia (IVRA), with satisfactory surgical conditions achieved within 20 minutes 5

Intraoral Nerve Blocks

  • 3-5 minutes for standard lignocaine injection 6
  • 34.4 seconds (mean) when alkalinized with sodium bicarbonate, compared to 109.8 seconds without alkalinization 6

Factors Affecting Onset Time

Alkalinization Significantly Accelerates Onset

  • Adding 8.4% sodium bicarbonate in a 1:10 dilution reduces onset time by approximately 70% for intraoral blocks 6
  • Buffering with sodium bicarbonate decreases injection pain while maintaining effectiveness 7, 3

Addition of Epinephrine

  • Epinephrine extends duration (90-200 minutes) but does not significantly delay onset 3
  • Provides faster onset and longer duration compared to lignocaine alone 3

Concentration and Site

  • Higher concentrations and specific anatomical sites affect absorption rate 2
  • Intratracheal administration results in the most rapid absorption 2

Clinical Implications for Timing

For intrapleural administration during pleurodesis, lignocaine must be given immediately before the sclerosant because its onset is almost instantaneous 1. The British Thoracic Society guidelines specifically recommend administering lignocaine (3 mg/kg; maximum 250 mg) intrapleurally just prior to sclerosant administration 1.

Important Safety Considerations

  • Wait at least 4 hours between lignocaine administration and other local anesthetic interventions to prevent cumulative toxicity 1, 7, 8
  • No nerve or fascial plane blocks should be performed until 4 hours after completion of an intravenous lignocaine infusion 1
  • Monitor for early signs of toxicity including circumoral numbness, facial tingling, and slurred speech 7, 3

Comparison with Other Local Anesthetics

Lignocaine is classified as having rapid onset compared to other local anesthetics 9:

  • Rapid onset agents: chloroprocaine, lignocaine, mepivacaine, prilocaine, and etidocaine 9
  • Slower onset agents: procaine, amethocaine, and bupivacaine 9
  • Ropivacaine has a mean onset time of 4.5 minutes (range 3.5-5.5 minutes), significantly slower than lignocaine's 1.3 minutes for digital blocks 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Safety of Lidocaine with Epinephrine in Digital Block

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Local Anesthesia Guidelines for Circumcision

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Alternative Local Anesthetics for Rapid Lidocaine Metabolizers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pharmacology of local anaesthetic agents.

British journal of anaesthesia, 1986

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.